Arsenal Capital Partners Analysis

Acquire healthcare technology firms like Certara and Knowtion Health; Invest in industrial growth companies such as Meridian Adhesives and Applied Adhesives; Execute platform transactions including acquisitions of adhesives and packaging businesses; Support management teams in scaling technology-rich operations; Facilitate divestitures such as sale of Seal For Life to Henkel

Arsenal Capital Partners is a specialized private equity firm that primarily focuses on the healthcare and industrial sectors. Their investment strategy emphasizes building high-growth companies through technology and innovation-rich approaches. Arsenal typically engages in late-stage investments, partnering with management teams and business owners to develop tailored strategies that enhance value in their target markets. The firm has a strong track record, having completed over 300 platform and add-on transactions and raised more than $10 billion in institutional funds.

Arsenal Capital Partners primarily invests in the United States, focusing on the lower middle market in the healthcare and industrial sectors.

1. 3DR Labs: Technology-enabled outsourced imaging solutions for radiology departments.
2. Accella: Formulated polyurethane products and solutions.
3. Airnov: Active packaging solutions for pharmaceuticals, diagnostics, and nutraceutical products.
4. Applied Adhesives: Value-added distributor of adhesives.
5. ATP Adhesive Systems: Water-based adhesive tapes.
6. AvCarb: Advanced materials serving renewable energy technology.
7. BioIVT: Biospecimens and other products for drug discovery and development.
8. CellCarta: Immune therapy and biologic drug development services.
9. Certara: Biosimulation software and technology to transform drug discovery and development.
10. Charter Brokerage: Third-party logistics services to petroleum, chemical, and airline industries.
11. Chroma Color: Color concentrates and additives for plastics.
12. DG3: Graphic, printing, and business services.
13. Epic Sciences: Liquid biopsy diagnostics solutions company.
14. Hopebridge: Autism therapy services.
15. OncoHealth: Digital health solutions for oncology.
16. Scientific Protein Laboratories: Active pharmaceutical ingredients.
17. WCG Clinical Services: Pharmaceutical clinical trial optimization solutions.

Arsenal Capital Partners has made several notable exits, including:

1. Certara: Arsenal announced the sale of Certara, a leading provider of technology-enabled drug development solutions, while retaining a significant minority investment stake. This exit highlights Arsenal's strategy of realizing value while maintaining a presence in high-growth companies.

2. TractManager: Another notable exit was TractManager, a company that provides healthcare contract management solutions. The details of the exit method were not specified, but it reflects Arsenal's focus on healthcare technology.

3. Seal For Life Industries: Arsenal exited this company through an acquisition, which was completed on February 15, 2024.

4. Airnov: This company was acquired on January 24, 2023, marking another successful exit for Arsenal.

These exits demonstrate Arsenal Capital Partners' strategy of investing in and growing companies in the healthcare and industrial sectors before realizing returns through acquisitions.

The management team of Arsenal Capital Partners includes the following key members:

• Joelle Marquis - President
• Frank Scrudato - Chief Financial Officer and Chief Compliance Officer
• George Abd - Operating Partner
• Dimitris Agrafiotis - Director, Digital, Analytics, & AI
• Sameen Ahmed - Administrative Assistant
• Irina Avrorina - Position not specified

Raised $10 billion in institutional funds; Completed 320+ platform and add-on transactions; 25 years of company-building experience; Acquired Knowtion Health; Invested in Certara with $449M stock purchase; Formed Digital and AI Advisory Board; Signed agreement to acquire Airnov Healthcare Packaging from Colorcon